发明名称 Novel compounds and therapeutic uses thereof
摘要 The invention discloses a novel series of compound represented by general formula (I), its derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, pharmaceutically acceptable salts, solvates wherein X, n, k, z, R1, R2, R3, R4, R5 and R6 are as defined in the specification that are useful in (i) normalizing elevated blood glucose levels in diabetes, (ii) treating disorders related to glucose intolerance and (iii) for scavenging free radicals of mammals. The invention also discloses pharmaceutically acceptable composition comprising these compounds, method for preparation of the compounds as defined above and method of treating mammals including human beings by administering an effective amount of said compounds to a subject in need thereof. The invention further discloses use of these compounds in the manufacture of a medicament useful for treatment of different disease conditions as stated above.
申请公布号 US2003225102(A1) 申请公布日期 2003.12.04
申请号 US20030408276 申请日期 2003.04.08
申请人 TORRENT PHARMACEUTICALS LTD. 发明人 SANKARANARAYANAN ALANGUDI
分类号 A61K31/401;A61K31/426;A61K31/4439;A61K31/454;A61K31/4545;A61K31/496;A61P1/00;A61P1/04;A61P1/12;A61P1/16;A61P3/04;A61P3/10;A61P5/06;A61P5/16;A61P5/48;A61P9/10;A61P11/06;A61P13/12;A61P19/02;A61P25/14;A61P25/16;A61P25/18;A61P25/28;A61P27/02;A61P31/18;A61P35/00;A61P39/06;A61P43/00;C07D207/16;C07D277/06;C07D401/12;C07D403/06;C07D417/06;C07D417/12;C07D417/14;(IPC1-7):A61K31/496;A61K31/421;C07D417/02;C07D413/02;C0743/02 主分类号 A61K31/401
代理机构 代理人
主权项
地址